DK0891344T3 - Antagonister til alpha-1-adrenergisk receptor - Google Patents
Antagonister til alpha-1-adrenergisk receptorInfo
- Publication number
- DK0891344T3 DK0891344T3 DK97919488T DK97919488T DK0891344T3 DK 0891344 T3 DK0891344 T3 DK 0891344T3 DK 97919488 T DK97919488 T DK 97919488T DK 97919488 T DK97919488 T DK 97919488T DK 0891344 T3 DK0891344 T3 DK 0891344T3
- Authority
- DK
- Denmark
- Prior art keywords
- antagonists
- alpha
- adrenergic receptor
- derivatives
- alpha1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62827696A | 1996-04-05 | 1996-04-05 | |
PCT/FR1997/000615 WO1997037983A1 (fr) | 1996-04-05 | 1997-04-04 | ANTAGONISTES DU RECEPTEUR α1-ADRENERGIQUE |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0891344T3 true DK0891344T3 (da) | 2003-04-07 |
Family
ID=24518205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97919488T DK0891344T3 (da) | 1996-04-05 | 1997-04-04 | Antagonister til alpha-1-adrenergisk receptor |
Country Status (15)
Country | Link |
---|---|
US (1) | US6300499B1 (ja) |
EP (1) | EP0891344B1 (ja) |
JP (1) | JP3845452B2 (ja) |
AT (1) | ATE229946T1 (ja) |
AU (1) | AU2393997A (ja) |
CZ (1) | CZ315098A3 (ja) |
DE (1) | DE69717978T2 (ja) |
DK (1) | DK0891344T3 (ja) |
ES (1) | ES2188936T3 (ja) |
HU (1) | HUP9901680A3 (ja) |
IL (1) | IL126411A0 (ja) |
NO (1) | NO984631L (ja) |
PL (1) | PL329190A1 (ja) |
RU (1) | RU2179554C2 (ja) |
WO (1) | WO1997037983A1 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5661163A (en) * | 1995-06-07 | 1997-08-26 | Merck & Co., Inc. | Alpha-1a adrenergic receptor antagonists |
GB9819860D0 (en) | 1998-09-12 | 1998-11-04 | Zeneca Ltd | Chemical compounds |
AU2002251409A1 (en) * | 2002-04-08 | 2003-10-20 | Ranbaxy Laboratories Limited | Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers |
EP1519726B1 (de) * | 2002-07-04 | 2007-02-21 | Schwarz Pharma Ag | Heteroarencarboxamide zur verwendung als dopamin-d3 liganden zur behandlung von zns-erkrankungen |
DE10251170A1 (de) * | 2002-10-31 | 2004-05-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
WO2006021344A1 (en) * | 2004-08-27 | 2006-03-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with alpha-1a adrenergic receptor (adra1a) |
US9056817B2 (en) * | 2011-09-12 | 2015-06-16 | Council Of Scientific And Industrial Research | Arylated β-dicarbonyl compounds and process for the preparation thereof |
CN103288745A (zh) * | 2013-06-25 | 2013-09-11 | 南方医科大学 | 一种2,6-二取代哒嗪酮类化合物及其应用 |
CN103304486A (zh) * | 2013-06-25 | 2013-09-18 | 南方医科大学 | 6-(4-芳基哌嗪-1-基)哒嗪-3(2h)-酮及其应用 |
WO2015029447A1 (ja) * | 2013-08-30 | 2015-03-05 | 興和株式会社 | 光学活性カルビノール化合物の製造方法 |
CN115124415A (zh) * | 2022-06-20 | 2022-09-30 | 西咸新区行易先进材料科技有限公司 | 一种合成阿卓乳酸的催化反应方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2722529A (en) * | 1955-11-01 | Amides of certain l-amevoalkyl-x-phenyl | ||
US2833770A (en) * | 1958-05-06 | Chj-chj | ||
NL8005133A (nl) * | 1980-09-12 | 1982-04-01 | Duphar Int Res | Fenylpiperazinederivaten met antiagressieve werking. |
CA1340113C (en) | 1988-05-24 | 1998-11-03 | Magid A. Abou-Gharbia | Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity |
DE69033393T2 (de) | 1989-04-22 | 2000-05-25 | Wyeth John & Brother Ltd | Tertiäre alkyl funktionalisierte Piperazin-Derivate |
FR2655988B1 (fr) * | 1989-12-20 | 1994-05-20 | Adir Cie | Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
DE4121276C2 (de) | 1991-06-27 | 1994-02-17 | Metallgesellschaft Ag | Verfahren zur Herstellung sulfathaltiger, basischer Polyaluminiumchlorid-Lösungen |
GB9200293D0 (en) | 1992-01-08 | 1992-02-26 | Wyeth John & Brother Ltd | Piperazine derivatives |
SE9201138D0 (sv) * | 1992-04-09 | 1992-04-09 | Astra Ab | Novel phthalimidoalkylpiperazines |
US5284990A (en) | 1992-07-16 | 1994-02-08 | Stratco, Inc. | Method for converting a hydrogen fluoride alkylation unit to a sulfuric acid alkylation unit |
US5349844A (en) | 1992-09-11 | 1994-09-27 | Trc Companies, Inc. | System and method for resonant filter mass monitoring |
SE9300295D0 (sv) | 1993-01-28 | 1993-01-28 | Benny Carlstroem | Foerfarande och anordning foer bindning av tandlagningsmaterial |
US6087346A (en) * | 1993-06-23 | 2000-07-11 | Cambridge Neuroscience, Inc. | Sigma receptor ligands and the use thereof |
US5414585A (en) | 1993-07-19 | 1995-05-09 | Quantum Corp. | Rotating tape edge guide |
IT1266582B1 (it) * | 1993-07-30 | 1997-01-09 | Recordati Chem Pharm | Derivati (di)azacicloesanici e diazacicloeptanici |
US5696123A (en) * | 1994-09-17 | 1997-12-09 | Boehringer Ingelheim Kg | Neurokinin antagonists |
-
1997
- 1997-04-04 CZ CZ983150A patent/CZ315098A3/cs unknown
- 1997-04-04 RU RU98119949/04A patent/RU2179554C2/ru not_active IP Right Cessation
- 1997-04-04 PL PL97329190A patent/PL329190A1/xx unknown
- 1997-04-04 DE DE69717978T patent/DE69717978T2/de not_active Expired - Fee Related
- 1997-04-04 IL IL12641197A patent/IL126411A0/xx unknown
- 1997-04-04 AU AU23939/97A patent/AU2393997A/en not_active Abandoned
- 1997-04-04 WO PCT/FR1997/000615 patent/WO1997037983A1/fr not_active Application Discontinuation
- 1997-04-04 EP EP97919488A patent/EP0891344B1/fr not_active Expired - Lifetime
- 1997-04-04 US US09/155,535 patent/US6300499B1/en not_active Expired - Fee Related
- 1997-04-04 ES ES97919488T patent/ES2188936T3/es not_active Expired - Lifetime
- 1997-04-04 JP JP53591997A patent/JP3845452B2/ja not_active Expired - Fee Related
- 1997-04-04 DK DK97919488T patent/DK0891344T3/da active
- 1997-04-04 HU HU9901680A patent/HUP9901680A3/hu unknown
- 1997-04-04 AT AT97919488T patent/ATE229946T1/de not_active IP Right Cessation
-
1998
- 1998-10-02 NO NO984631A patent/NO984631L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2393997A (en) | 1997-10-29 |
RU2179554C2 (ru) | 2002-02-20 |
US6300499B1 (en) | 2001-10-09 |
PL329190A1 (en) | 1999-03-15 |
NO984631D0 (no) | 1998-10-02 |
EP0891344A1 (fr) | 1999-01-20 |
DE69717978T2 (de) | 2003-10-02 |
JP3845452B2 (ja) | 2006-11-15 |
HUP9901680A3 (en) | 2000-12-28 |
NO984631L (no) | 1998-12-02 |
ATE229946T1 (de) | 2003-01-15 |
JP2000508310A (ja) | 2000-07-04 |
CZ315098A3 (cs) | 1999-04-14 |
WO1997037983A1 (fr) | 1997-10-16 |
ES2188936T3 (es) | 2003-07-01 |
HUP9901680A2 (hu) | 1999-09-28 |
EP0891344B1 (fr) | 2002-12-18 |
IL126411A0 (en) | 1999-05-09 |
DE69717978D1 (de) | 2003-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200000220A1 (ru) | Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы | |
BR9807674A (pt) | Inibidores bicìclicos da proteìna farnesil transferase | |
DK0891344T3 (da) | Antagonister til alpha-1-adrenergisk receptor | |
ATE228502T1 (de) | Substituierte analoge von indol-3-carbinol und von diindolmethan als antiestrogene | |
DK0480950T3 (da) | Kombinationsterapi til profylakse for og/eller behandling af godartet prostatahypertrofi | |
YU7797A (sh) | Kombinovana terapija za osteoporozu | |
BR9811099A (pt) | Inibidores de urocinase | |
AU2443184A (en) | Benzazocinones and benzazoninones | |
ZA986673B (en) | Use of a combination of an inhibitor of converting enzyme and a diuretic for treating microcirculatory disorders | |
EP0646007A4 (ja) | ||
ES2060818T3 (es) | Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa. | |
DK0874625T3 (da) | Indanderivater til antipsykotiske præparater | |
BG103553A (en) | Benzopyranopyrol and benzopyranopyridine alpha-1 adrenergic compounds | |
KR950700746A (ko) | 양성 전립선 비대를 치료하는 조성물 및 방법(Compositions and Methods For Treating Benign Prostatic Hypertrophy) | |
PT950056E (pt) | N-(piridinilamino) isoindolinas e compostos relacionados | |
AU9128998A (en) | Composition and method for the treatment of benign prostatic hyperplasia and prostatitis | |
TR199701613T1 (xx) | Selim prostatik hiperplasyan�n tedavisi i�in melatonin agonistleri. | |
NZ333506A (en) | Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use | |
CA2251016A1 (fr) | Antagonistes du recepteur .alpha.1-adrenergique | |
IT1291076B1 (it) | Procedimento di inertizzazione di rifiuti contenenti amianto. | |
AU6374798A (en) | Methods and compositions of (+) doxazosin for the treatment of hypertension and benign prostatic hyperplasia |